Progressive Familial Intrahepatic Cholestasis
📧 Sign up to get email alerts when something new happens for Progressive Familial Intrahepatic Cholestasis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-01Clinical Trial Update: A Study of the Effectiveness, Safety and the Long-term Outcomes of Participants With Progressive Familial Intrahepatic Cholestasis (PFIC) Who Take Odevixibat (Bylvay) in South Korea
This is an ongoing clinical trial update evaluating the effectiveness, safety, and long-term outcomes of odevixibat (Bylvay) in participants…
-
CLINICAL_TRIALS research · 2026-04-01Clinical Trial Update: A Study to Assess the Genetic Variations in Bile Flow Disorders: Linking Progressive Familial Intrahepatic Cholestasis (PFIC)-Related Genes to Symptoms in Adults With Recurrent Cholestasis in Spain
A recruiting clinical trial in Spain to study genetic variations in PFIC-related genes and their link to symptoms in adults with recurrent c…
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: DEFINING THE GENETIC DRIVERS OF ADULT-ONSET CHOLESTATIC LIVER DISEASE [NA]
This clinical trial study aims to define the genetic drivers of adult-onset cholestatic liver disease and is currently in the recruiting sta…
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: Retrospective Observational Study of Odevixibat Outcomes in Patients With PFIC Versus an External Control Cohort (OvEC-PFIC)
Ipsen is conducting a retrospective observational study of odevixibat in Progressive Familial Intrahepatic Cholestasis (PFIC) comparing outc…
-
CLINICAL_TRIALS research · 2026-03-10Clinical Trial Update: Pediatric Evaluation and Registry for Liver Cholestasis in Canada
This clinical trial registry update describes a Pediatric Evaluation and Registry for Liver Cholestasis in Canada. It focuses on Progressive…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-05-25Clinical Trial Update: Long-Term SafEty and Clinical Outcomes of LivmArli in Patients in the United States (LEAP-US)
ClinicalTrials.gov update indicates that the long-term safety and clinical outcomes study of Livmarli (maralixibat) for Alagille syndrome an…
-
CLINICAL_TRIALS research · 2025-01-24Clinical Trial Update: Prospective Analysis of the Treatment of Progressive Familial Intrahepatic Cholestasis (TreatFIC)
The TreatFIC study is a prospective analysis of treatment approaches for Progressive Familial Intrahepatic Cholestasis and is currently recr…
-
CLINICAL_TRIALS research · 2025-01-17Clinical Trial Update: NAtural Course and Prognosis of PFIC and Effect of Biliary Diversion
This clinical trial update discusses the natural course and prognosis of Progressive Familial Intrahepatic Cholestasis and examines the impa…
-
CLINICAL_TRIALS research · 2025-01-17Clinical Trial Update: Genotype-phenotype Relationship Between Cryptogenic Cholestasis and Familial Intrahepatic Cholestasis
This ClinicalTrials.gov entry reports an ongoing study examining the genotype-phenotype relationship between cryptogenic cholestasis and fam…
-
CLINICAL_TRIALS research · 2025-01-16Clinical Trial Update: Familial Intrahepatic Cholestasis-related Genes Associated with Disease Susceptibility in Hepato-biliary Cancers
A clinical trial is exploring genetic factors related to Progressive familial intrahepatic cholestasis and their association with susceptibi…
-
CLINICAL_TRIALS research · 2013-02-06Clinical Trial Update: Buphenyl Therapy for Byler's Disease
Clinical trial update indicates that Buphenyl therapy for progressive familial intrahepatic cholestasis (Byler disease) is no longer availab…